Statements (46)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Gavis_Pharmaceuticals
|
| gptkbp:CEO |
gptkb:Vinita_Gupta
|
| gptkbp:focusesOn |
Pharmaceuticals
|
| gptkbp:foundedIn |
1968
|
| gptkbp:hasAwards |
Best Employer Award
Excellence in Quality Award Innovation in Pharma Award Best_Corporate_Social_Responsibility_Award Pharma_Company_of_the_Year |
| gptkbp:hasEmployees |
Over 20,000
|
| gptkbp:hasPartnershipsWith |
Academic Institutions
Regulatory Authorities Various Research Institutions Healthcare_Providers |
| gptkbp:hasProductLine |
Antibiotics
Cardiovascular Drugs Nutraceuticals Dermatology Products Oncology Products Respiratory Drugs Diabetes Drugs Central_Nervous_System_Drugs Women's_Health_Products Pediatric_Products |
| gptkbp:hasResearchInterest |
Manufacturing Plants
Regulatory Affairs Departments R&D_Centers Clinical_Research_Units Quality_Control_Labs |
| gptkbp:hasResidence |
$2.5 billion
|
| gptkbp:hasSubsidiary |
gptkb:Lupin_Pharmaceuticals,_Inc.
gptkb:Lupin_Europe_Limited Lupin_Australia_Pty_Ltd. |
| gptkbp:headquarteredIn |
gptkb:Mumbai
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lupin Life Sciences
|
| gptkbp:market |
gptkb:Asia
gptkb:Latin_America gptkb:North_America Africa Europe Middle_East |
| gptkbp:offers |
Branded Drugs
Generic_Drugs |
| gptkbp:operatesIn |
Global_Markets
|
| gptkbp:partOf |
gptkb:Lupin_Limited
|